Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 22.50
-0.80 (-3.43%)
Last updated: Dec 5, 2025, 2:09 PM CET
Xlife Sciences AG Revenue
Xlife Sciences AG had revenue of 354.32K CHF in the half year ending June 30, 2025, with 1.82% growth. This brings the company's revenue in the last twelve months to 839.38K, down -15.24% year-over-year. In the year 2024, Xlife Sciences AG had annual revenue of 834.88K, down -15.54%.
Revenue (ttm)
839.38K
Revenue Growth
-15.24%
P/S Ratio
154.60
Revenue / Employee
49.38K
Employees
17
Market Cap
129.77M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 44.95B |
| Galderma Group AG | 3.73B |
| Lonza Group AG | 7.09B |
| Alcon | 8.12B |
| Sandoz Group AG | 8.42B |
| Straumann Holding AG | 2.58B |
| Sonova Holding AG | 3.85B |